Publications
A203 INCIDENCE AND PREDICTORS OF NON-HEPATIC CANCERS IN ALCOHOL RELATED LIVER DISEASE IN THE WALDO COHORT
Hindi, Z,
Brahmania, M,
Arab, J,
Shi, N,
Rajoriya, N,
Aithal, G,
Allison, M,
Hagström, H,
Likhitsup, A,
McCune, A,
Masson, S,
Parker, R,
Journal of the Canadian Association of Gastroenterology, 2022 Feb; DOI:10.1093/jcag/gwab049.202 DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
Graham, L,
Green, E,
Park, JJ,
Kellezi, O,
Hwang, C,
Barata, PC,
Bilen, MA,
Kilari, D,
Clingerman, M,
Tripathi, A,
Labriola, M,
Rothstein, S,
Garje, R,
Koshkin, VS,
Patel, VG,
Dorff, TB,
Armstrong, AJ,
McKay, RR,
Alva, AS,
Schweizer, MT,
Journal of Clinical Oncology, 2022 Feb; DOI:10.1200/jco.2022.40.6_suppl.129 Abstract PD13-02: Phase Ib expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER+ metastatic breast cancer
Layman, R,
Wesolowski, R,
Han, H,
Specht, JM,
Stringer-Reasor, EM,
Dees, EC,
Kabos, P,
Mayer, IA,
Vaishampayan, U,
Lu, J,
Gogineni, K,
Bardia, A,
Schott, AF,
Abu-Khalaf, M,
Howkins, D,
Sullivan, B,
Gorbatchevsky, I,
Rugo, H,
Cancer Research, 2022 Feb; DOI:10.1158/1538-7445.sabcs21-pd13-02 Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors
Bhuniya, R,
Yuan, X,
Bai, L,
Howie, KL,
Wang, R,
Li, W,
Park, F,
Yang, C-Y,
ACS Med Chem Lett, 2022 Feb; DOI:10.1021/acsmedchemlett.1c00544 Structural effects of morpholine replacement in ZSTK474 on Class I PI3K isoform inhibition: Development of novel MEK/PI3K bifunctional inhibitors
Van Dort, ME,
Jang, Y,
Bonham, CA,
Heist, K,
Palagama, DSW,
McDonald, L,
Zhang, EZ,
Chenevert, TL,
Luker, GD,
Ross, BD,
Eur J Med Chem, 2022 Feb; DOI:10.1016/j.ejmech.2021.113996 Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequences
Chemaitilly, W,
Li, Z,
Brinkman, TM,
Delaney, A,
Huang, S,
Bjornard, KL,
Lam, CG,
Wilson, CL,
Barnes, N,
Clark, KL,
Krasin, MJ,
Metzger, ML,
Sheyn, A,
Bishop, MW,
Sabin, ND,
Howell, RM,
Helmig, S,
Shulkin, BL,
Triplett, BM,
Pui, C-H,
Gajjar, A,
Srivastava, DK,
Green, DM,
Armstrong, GT,
Robison, LL,
Hudson, MM,
Ness, KK,
Sklar, CA,
Krull, KR,
Cancer, 2022 Feb; DOI:10.1002/cncr.33969 Functional decline in hospitalized patients with COVID-19 in the early months of the pandemic
Daunter, AK,
Bowman, A,
Danko, J,
Claflin, ES,
Kratz, AL,
PM R, 2022 Feb; DOI:10.1002/pmrj.12624 Fibrin-Associated, EBV-Negative Diffuse Large B-Cell Lymphoma Arising in Atrial Myxoma: Expanding the Spectrum of the Entity
Baugh, L,
Brown, N,
Song, JY,
Pandya, S,
Montoya, V,
Perry, AM,
Int J Surg Pathol, 2022 Feb; DOI:10.1177/10668969211014959 Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Furman, WL,
McCarville, B,
Shulkin, BL,
Davidoff, A,
Krasin, M,
Hsu, C-W,
Pan, H,
Wu, J,
Brennan, R,
Bishop, MW,
Helmig, S,
Stewart, E,
Navid, F,
Triplett, B,
Santana, V,
Santiago, T,
Hank, JA,
Gillies, SD,
Yu, A,
Sondel, PM,
Leung, WH,
Pappo, A,
Federico, SM,
J Clin Oncol, 2022 Feb; DOI:10.1200/JCO.21.01375 In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge.
Chan, PS,
Spertus, JA,
Kennedy, K,
Nallamothu, BK,
Starks, MA,
Girotra, S,
Circ Cardiovasc Qual Outcomes, 2022 Feb; DOI:10.1161/CIRCOUTCOMES.121.008420 Using Tailored Messages to Target Overuse of Low-Value Breast Cancer Care in Older Women
Dossett, LA,
Mott, NM,
Bredbeck, BC,
Wang, T,
Jobin, CT,
Hughes, TM,
Hawley, ST,
Zikmund-Fisher, BJ,
J Surg Res, 2022 Feb; DOI:10.1016/j.jss.2021.10.005 Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature
Nallandhighal, S,
Vince, R,
Karim, R,
Groves, S,
Stangl-Kremser, J,
Russell, C,
Hu, K,
Pham, T,
Cani, AK,
Liu, C-J,
Zaslavsky, A,
Mehra, R,
Cieslik, M,
Morgan, TM,
Palapattu, GS,
Udager, AM,
Salami, SS,
Eur Urol Oncol, 2022 Feb; DOI:10.1016/j.euo.2021.10.007 Advanced CT and MR Imaging of the Posttreatment Head and Neck
Lobo, R,
Turk, S,
Bapuraj, JR,
Srinivasan, A,
Neuroimaging Clin N Am, 2022 Feb; DOI:10.1016/j.nic.2021.08.013 Similar Quality of Life After Conventional and Robotic Transhiatal Esophagectomy
Williams, AM,
Kathawate, RG,
Zhao, L,
Grenda, TR,
Bergquist, CS,
Brescia, AA,
Kilbane, K,
Barrett, E,
Chang, AC,
Lynch, W,
Lin, J,
Wakeam, E,
Lagisetty, KH,
Orringer, MB,
Reddy, RM,
Ann Thorac Surg, 2022 Feb; DOI:10.1016/j.athoracsur.2021.03.018 Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin
Curran, C,
Adib, E,
Kazakova, V,
Grivas, P,
Diamantopoulos, LN,
Alva, AS,
Su, C,
Jain, RK,
Tandon, A,
Necchi, A,
Marandino, L,
Plastini, TM,
Merchan, JR,
Sonpavde, G,
Clin Genitourin Cancer, 2022 Feb; DOI:10.1016/j.clgc.2021.08.002 Impact of Completion Lymphadenectomy on Quality of Life for Head and Neck Cutaneous Melanoma
Farlow, JL,
McLean, SA,
Peddireddy, N,
Bradford, CR,
Malloy, KM,
Stucken, CL,
VanKoevering, KK,
Spector, ME,
Rosko, AJ,
Otolaryngol Head Neck Surg, 2022 Feb; DOI:10.1177/01945998211007442 Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts
Ötleş, E,
Denton, BT,
Qu, B,
Murali, A,
Merdan, S,
Auffenberg, GB,
Hiller, SC,
Lane, BR,
George, AK,
Singh, K,
J Urol, 2022 Feb; DOI:10.1097/JU.0000000000002230 T-Cell Subsets as Potential Biomarkers for Hepatobiliary Cancers and Selection of Immunotherapy Regimens as a Treatment Strategy.
Kumar-Sinha, C,
Sahai, V,
J Natl Compr Canc Netw, 2022 Feb; DOI:10.6004/jnccn.2021.7097 Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
McGregor, BA,
Xie, W,
Adib, E,
Stadler, WM,
Zakharia, Y,
Alva, A,
Michaelson, MD,
Gupta, S,
Lam, ET,
Farah, S,
Nassar, AH,
Wei, XX,
Kilbridge, KL,
Harshman, L,
Signoretti, S,
Sholl, L,
Kwiatkowski, DJ,
McKay, RR,
Choueiri, TK,
JCO Precis Oncol, 2022 Feb; DOI:10.1200/PO.21.00448 Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms?
Townsend, TN,
Salz, T,
Haffajee, RL,
Caram, MEV,
Chino, F,
Bohnert, ASB,
J Pain Symptom Manage, 2022 Feb; DOI:10.1016/j.jpainsymman.2021.09.014 PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma
Liu, F,
Gao, Y,
Xu, B,
Xiong, S,
Yi, S,
Sun, J,
Chen, Z,
Liu, X,
Li, Y,
Lin, Y,
Wen, Y,
Qin, Y,
Yang, S,
Li, H,
Tejasvi, T,
Tsoi, L,
Tu, P,
Ren, X,
Wang, Y,
Blood, 2022 Jan; DOI:10.1182/blood.2021012091 Prevalence and determinants of oral and cervicogenital HPV infection: baseline analysis of the MHOC cohort study
Brouwer, A,
Campredon, L,
Walline, H,
Marinelli, B,
Goudsmit, C,
Thomas, T,
Delinger, R,
Lau, YK,
Andrus, E,
Yost, M,
McCloskey, J,
Sullivan, T,
Mortensen, A,
Huang, S,
Murphy, K,
Cheng, B,
Stanek, K,
Nair, T,
Carey, T,
Meza, R,
Eisenberg, M,
2022 Jan; DOI:10.1101/2022.01.15.22269344 Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
Cao, Y,
Haring, CT,
Brummel, C,
Bhambhani, C,
Aryal, M,
Lee, C,
Heft Neal, M,
Bhangale, A,
Gu, W,
Casper, K,
Malloy, K,
Sun, Y,
Shuman, A,
Prince, ME,
Spector, ME,
Chinn, S,
Shah, J,
Schonewolf, C,
McHugh, JB,
Mills, RE,
Tewari, M,
Worden, FP,
Swiecicki, PL,
Mierzwa, M,
Brenner, JC,
Clin Cancer Res, 2022 Jan; DOI:10.1158/1078-0432.CCR-21-2338 ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization
Qin, T,
Mullan, B,
Ravindran, R,
Messinger, D,
Siada, R,
Cummings, JR,
Harris, M,
Muruganand, A,
Pyaram, K,
Miklja, Z,
Reiber, M,
Garcia, T,
Tran, D,
Danussi, C,
Brosnan-Cashman, J,
Pratt, D,
Zhao, X,
Rehemtulla, A,
Sartor, MA,
Venneti, S,
Meeker, AK,
Huse, JT,
Morgan, MA,
Lowenstein, PR,
Castro, MG,
Yadav, VN,
Koschmann, C,
Cell Rep, 2022 Jan; DOI:10.1016/j.celrep.2021.110216 Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
Wolchok, JD,
Chiarion-Sileni, V,
Gonzalez, R,
Grob, J-J,
Rutkowski, P,
Lao, CD,
Cowey, CL,
Schadendorf, D,
Wagstaff, J,
Dummer, R,
Ferrucci, PF,
Smylie, M,
Butler, MO,
Hill, A,
Márquez-Rodas, I,
Haanen, JBAG,
Guidoboni, M,
Maio, M,
Schöffski, P,
Carlino, MS,
Lebbé, C,
McArthur, G,
Ascierto, PA,
Daniels, GA,
Long, GV,
Bas, T,
Ritchings, C,
Larkin, J,
Hodi, FS,
J Clin Oncol, 2022 Jan; DOI:10.1200/JCO.21.02229 